Protein Assays

Protein Assays

Global Protein Assays Market to Reach US$3.7 Billion by 2030

The global market for Protein Assays estimated at US$2.4 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Protein Assays Kits, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$938.4 Million by the end of the analysis period. Growth in the Protein Assays Instruments & Accessories segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$637.2 Million While China is Forecast to Grow at 5.9% CAGR

The Protein Assays market in the U.S. is estimated at US$637.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$575.5 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Protein Assays Market - Key Trends and Drivers Summarized

Analyzing the Potential: The Expanding Market for Protein Assays

Protein assays are fundamental tools in life sciences research, enabling the quantification and analysis of proteins in various biological samples. These assays are critical for understanding protein function, structure, and interactions, which are essential for developing new drugs, diagnostics, and therapies. The increasing focus on proteomics, the large-scale study of proteins, has significantly driven the demand for protein assays. In fields such as biotechnology, pharmaceuticals, and clinical diagnostics, protein assays are indispensable for quality control, drug discovery, and disease diagnosis. The growing prevalence of chronic diseases and the need for personalized medicine further underscore the importance of accurate and reliable protein assays in modern healthcare.

How Are Technological Advancements Influencing the Market?

Technological advancements have played a pivotal role in the evolution of protein assays. The development of high-throughput assays and automated systems has revolutionized the field, enabling the rapid and accurate quantification of proteins in complex biological samples. Innovations in fluorescence and luminescence-based assays have improved sensitivity and specificity, allowing researchers to detect low-abundance proteins with greater precision. The integration of microfluidics and lab-on-a-chip technologies has also enhanced the efficiency and scalability of protein assays, making them more accessible to researchers across various disciplines. Additionally, advancements in bioinformatics and data analysis tools have facilitated the interpretation of complex protein data, further driving the adoption of advanced protein assays in research and clinical settings.

What Are the Emerging Applications of Protein Assays?

Protein assays are increasingly being applied in emerging fields such as personalized medicine, biomarker discovery, and immunotherapy. In personalized medicine, protein assays are used to identify specific biomarkers that can guide the selection of targeted therapies for individual patients. The rise of immunotherapy, particularly in cancer treatment, has also driven the demand for protein assays that can assess the expression levels of immune checkpoint proteins, which are critical for determining the efficacy of these therapies. Additionally, protein assays are being used in the development of novel diagnostic tools, such as point-of-care tests, that provide rapid and accurate results at the patient’s bedside. These emerging applications are expanding the scope and utility of protein assays in both research and clinical practice.

What Are the Key Growth Drivers in the Market?

The growth in the protein assays market is driven by several factors. The increasing focus on proteomics and the need for advanced tools to study protein function and interactions are major drivers. Technological advancements, such as the development of high-throughput and automated assays, have significantly improved the efficiency and accuracy of protein quantification, driving their adoption in research and clinical settings. The growing prevalence of chronic diseases and the demand for personalized medicine have also spurred the need for reliable protein assays. Emerging applications, particularly in biomarker discovery and immunotherapy, are further expanding the market. Additionally, the integration of advanced data analysis tools and bioinformatics is enhancing the utility of protein assays, making them indispensable in modern life sciences research.

Select Competitors (Total 11 Featured) -

• Abcam PLC
• Bio-Rad Laboratories, Inc.
• Biovision Inc.
• Cell Signaling Technology, Inc.
• GE Healthcare Life Sciences
• Geno Technology Inc.
• Lonza Group AG
• Merck KgaA
• Novus Biologicals LLC
• PerkinElmer, Inc.
• Promega Corporation
• Thermo Fisher Scientific, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.